MediWound announced multiple clinical partnerships on August 14, 2025, including collaborations with Kerecis, MiMedx, Convatec, and Essity.
1 report, 1 independent
Updated Aug 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MediWound announced multiple clinical partnerships on August 14, 2025, including collaborations with Kerecis, MiMedx, Convatec, and Essity.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- MiMedx invested in Vaporox, a Denver-based company, and Vaporox's Vaporous Hyperoxia Therapy received 510(k) clearance from the FDA for its wound care offerings.Sub-event
MediWound formed clinical partnerships with Kerecis, MiMedx, Convatec, and Essity.1 source
Keep exploring
The entities involved
-
MediWound (Germany)
company in Rüsselsheim, Germany
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireMediWound Reports Second Quarter 2025 Financial Results and Provides Corporate Update VALUE Phase III Trial of EscharEx® in Venous Leg Ulcers Continues to Enroll Patients NexoBrid® Manufacturing Expa